Aquestive Therapeutics (AQST) EBITDA Margin (QoQ) (2017 - 2026)
Aquestive Therapeutics (AQST) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.08 Bn | 2.15 Bn |
| 3 | Zoetis | 32.52 Bn | 30.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.14 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.93 Bn | 18.04 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.49 Bn | 15.10 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | Aquestive Therapeutics | 578.10 Mn | 578.10 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,040.00 |
| Mar 31, 2026 | -12,337.00 |
| Dec 31, 2025 | 18,390.00 |
| Sep 30, 2025 | 2,402.00 |
| Jun 30, 2025 | 10,843.00 |
| Mar 31, 2025 | -10,765.00 |
| Dec 31, 2024 | -5,321.00 |
| Sep 30, 2024 | -6,149.00 |
| Jun 30, 2024 | 7,459.00 |
| Mar 31, 2024 | -4,470.00 |
| Dec 31, 2023 | -1,133.00 |
| Sep 30, 2023 | 1,351.00 |
| Jun 30, 2023 | 957.00 |
| Mar 31, 2023 | 5,893.00 |
| Dec 31, 2022 | -2,306.00 |
| Sep 30, 2022 | 8,229.00 |
| Jun 30, 2022 | -8,016.00 |
| Mar 31, 2022 | 2,597.00 |
| Dec 31, 2021 | -4,537.00 |
| Sep 30, 2021 | 26,588.00 |